GLOBAL CRISPR MARKET 2021-2028

Lifesciences | Diagnostic & Biotechnology

GLOBAL CRISPR MARKET 2021-2028

Market by Product, Application, Industry Verticals, and Geography | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

CRISPR, Clustered Regularly Interspaced Short Palindromic Repeats, is considered the hallmark of bacterial defense systems that form the basis of CRISPR-Cas9 genome editing technology. CRISPR-Cas (CRISPR-associated proteins) is a revolutionary tool that helps biomedical research to grow. As per Triton Market Research, the global CRISPR market was valued at $1284.07 million in 2020 and is expected to reach $4521.76 million by 2028, growing at a CAGR of 20.38% during the forecasted period 2021 to 2028.


Report scope can be customized per your requirements. Request For Customization

Triton’s report on CRISPR provides an in-depth insight into the market. The detailed analysis of the market includes key insights, Porter’s five forces analysis, market attractiveness index, vendor scorecard, legal & regulatory framework, patent outlook, funding outlook, key strategies, key impact analysis, and impact of COVID-19 on the market.

The market is driven by several factors, such as the growing lifestyle-oriented diseases, the high prevalence of genetic disorders, and a rise in awareness about gene therapeutics. The advancements in gene-based therapy in the agricultural sector are increasing due to CRISPR-Cas’s ability to precisely manipulate the plant genomes on a global level. Furthermore, CRISPR-Cas aims to facilitate the upbringing of high-quality crops, which further uses enhancements in y-aminobutyric acid and carotenoid, along with a reduction in high oleic acid contents and phytic acid.

Further, the increase in the use of prospective applications of CRISPR technology is anticipated to positively impact this market’s growth, creating opportunities for the CRISPR market. For example, in June 2017, the scientists at Synthetic Genomics and ExxonMobil created an oil-rich strain of algae with the help of CRISPR tools that could be turned into fuel. Besides, some researchers are trying to use CRISPR technology to reverse the extinction of some animals and plants.

Conversely, the market has been negatively affected due to the growing ethical issues relating to technology use. This moral debate arises after the modifications on any living organism’s genes through the use of CRISPR. Additionally, more concerns arise when the same technique is used to modify insects, animals, plants, and even micro-organisms. Along with this, factors such as likely misuse of gene-editing tools and the absence of healthcare budgets in developing countries are restricting the growth of the CRISPR market.


Key geographies covered in the global CRISPR market are:

•           North America: United States and Canada

•           Europe: United Kingdom, France, Germany, Spain, Italy, Russia, and Rest of Europe

•           Asia-Pacific: China, Japan, India, South Korea, ASEAN Countries, Australia & New Zealand, and Rest of Asia-Pacific

•           Latin America: Brazil, Mexico, and Rest of Latin America

•           Middle East and Africa: Saudi Arabia, Turkey, United Arab Emirates, South Africa, and Rest of Middle East & Africa

The segmentation analysis of the CRISPR market includes:

•           Market by Product:

           o          Plasmids

           o          Vectors

           o          Proteins

           o          Designing Tools

           o          gRNA

           o          Control Kits

           o          Library

           o          Other Products

•           Market by Application:

           o          Genome Editing/Genetic Engineering

           o          gRNA Database/Gene Library

           o          CRISPR Plasmid

           o          Human Stem Cells

           o          Cell Line Engineering

•           Market by Industry Verticals:

           o          Therapeutics and Drug Discovery

           o          Biological Research

           o          Agricultural Biotech

           o          Industrial Biotech

The eminent players in the CRISPR market are Horizon Discovery Group, Caribou Biosciences Inc, Intellia Therapeutics, Novartis International AG, OriGene Technologies Inc, Editas Medicine, Addgene, Lonza Group Ltd, Precision Biosciences, Integrated DNA Technologies, Cellectis Bioresearch SAS, New England Biolabs, CRISPR Therapeutics AG, Synthego Corporation, and Genscript.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. GLOBAL CRISPR MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON CRISPR MARKET

2.2. KEY INSIGHTS

2.2.1. INDUSTRIAL BIOTECH IS THE FASTEST GROWING INDUSTRY VERTICAL

2.2.2. REWRITING OF GENETIC DISORDERS THROUGH GENOME SURGERY

2.2.3. INCREASING USAGE OF PROSPECTIVE APPLICATIONS OF CRISPR TECHNOLOGY

2.3. PORTER’S FIVE FORCES ANALYSIS

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTES

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. THREAT OF COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. LEGAL & REGULATORY OUTLOOK

2.7. PATENT OUTLOOK

2.8. FUNDING OUTLOOK

2.9. KEY IMPACT ANALYSIS

2.9.1. COST

2.9.2. ACCURACY

2.9.3. EASY TO USE

2.10. KEY MARKET STRATEGIES

2.10.1. ACQUISITIONS

2.10.2. PRODUCT LAUNCHES

2.10.3. CONTRACTS & PARTNERSHIPS

2.10.4. BUSINESS EXPANSIONS & DIVESTITURES

2.11. MARKET DRIVERS

2.11.1. GROWING LIFESTYLE-ORIENTED DISEASES

2.11.2. SURGING PREVALENCE OF GENETIC DISEASES

2.12. MARKET CHALLENGES

2.12.1. GROWING ETHICAL ISSUES REGARDING TECHNOLOGY USE

2.12.2. LIKELY MISUSE OF GENE-EDITING TOOL

2.12.3. ABSENCE OF HEALTHCARE BUDGETS IN DEVELOPING COUNTRIES

2.13. MARKET OPPORTUNITIES

2.13.1. ADVANCEMENTS IN GENE-BASED THERAPY IN THE AGRICULTURAL SECTOR

2.13.2. INCREASED NEED FOR CLINICAL TRIALS

2.13.3. RISE IN AWARENESS ABOUT GENE THERAPEUTICS

3. GLOBAL CRISPR MARKET OUTLOOK - BY PRODUCT

3.1. PLASMIDS

3.2. VECTORS

3.3. PROTEINS

3.4. DESIGNING TOOLS

3.5. GRNA

3.6. CONTROL KITS

3.7. LIBRARY

3.8. OTHER PRODUCTS

4. GLOBAL CRISPR MARKET OUTLOOK - BY APPLICATION

4.1. GENOME EDITING/GENETIC ENGINEERING

4.2. CRISPR PLASMID

4.3. HUMAN STEM CELLS

4.4. GRNA DATABASE/GENE LIBRARY

4.5. CELL LINE ENGINEERING

5. GLOBAL CRISPR MARKET OUTLOOK - BY INDUSTRY VERTICALS

5.1. THERAPEUTICS AND DRUG DISCOVERY

5.2. BIOLOGICAL RESEARCH

5.3. AGRICULTURAL BIOTECH

5.4. INDUSTRIAL BIOTECH

6. GLOBAL CRISPR MARKET – REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1. MARKET BY PRODUCT

6.1.2. MARKET BY APPLICATION

6.1.3. MARKET BY INDUSTRY VERTICALS

6.1.4. COUNTRY ANALYSIS

6.1.4.1. UNITED STATES

6.1.4.2. CANADA

6.2. EUROPE

6.2.1. MARKET BY PRODUCT

6.2.2. MARKET BY APPLICATION

6.2.3. MARKET BY INDUSTRY VERTICALS

6.2.4. COUNTRY ANALYSIS

6.2.4.1. UNITED KINGDOM

6.2.4.2. GERMANY

6.2.4.3. FRANCE

6.2.4.4. SPAIN

6.2.4.5. ITALY

6.2.4.6. RUSSIA

6.2.4.7. REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1. MARKET BY PRODUCT

6.3.2. MARKET BY APPLICATION

6.3.3. MARKET BY INDUSTRY VERTICALS

6.3.4. COUNTRY ANALYSIS

6.3.4.1. CHINA

6.3.4.2. JAPAN

6.3.4.3. INDIA

6.3.4.4. SOUTH KOREA

6.3.4.5. ASEAN COUNTRIES

6.3.4.6. AUSTRALIA & NEW ZEALAND

6.3.4.7. REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1. MARKET BY PRODUCT

6.4.2. MARKET BY APPLICATION

6.4.3. MARKET BY INDUSTRY VERTICALS

6.4.4. COUNTRY ANALYSIS

6.4.4.1. BRAZIL

6.4.4.2. MEXICO

6.4.4.3. REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1. MARKET BY PRODUCT

6.5.2. MARKET BY APPLICATION

6.5.3. MARKET BY INDUSTRY VERTICALS

6.5.4. COUNTRY ANALYSIS

6.5.4.1. UNITED ARAB EMIRATES

6.5.4.2. SAUDI ARABIA

6.5.4.3. TURKEY

6.5.4.4. SOUTH AFRICA

6.5.4.5. REST OF MIDDLE EAST & AFRICA

7. COMPETITIVE LANDSCAPE

7.1. ADDGENE

7.2. CARIBOU BIOSCIENCES INC

7.3. CELLECTIS BIORESEARCH SAS

7.4. CRISPR THERAPEUTICS AG

7.5. EDITAS MEDICINE

7.6. GENSCRIPT

7.7. HORIZON DISCOVERY GROUP

7.8. INTEGRATED DNA TECHNOLOGIES

7.9. INTELLIA THERAPEUTICS

7.10. LONZA GROUP LTD

7.11. NEW ENGLAND BIOLABS

7.12. NOVARTIS INTERNATIONAL AG

7.13. ORIGENE TECHNOLOGIES INC

7.14. PRECISION BIOSCIENCES

7.15. SYNTHEGO CORPORATION

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of Tables

TABLE 1: GLOBAL CRISPR MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION)   

TABLE 2: VENDOR SCORECARD        

TABLE 3: REGULATORY FRAMEWORK         

TABLE 4: FUNDING OUTLOOK OF PUBLIC COMPANIES  

TABLE 5: FUNDING OUTLOOK OF PRIVATE COMPANIES

TABLE 6: FUNDING OUTLOOK OF GOVERNMENT ORGANIZATIONS   

TABLE 7: GLOBAL CRISPR MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)         

TABLE 8: GLOBAL CRISPR MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)  

TABLE 9: GLOBAL CRISPR MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)           

TABLE 10: GLOBAL CRISPR MARKET, BY GEOGRAPHY, 2021-2028 (IN $ MILLION) 

TABLE 11: NORTH AMERICA CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION) 

TABLE 12: NORTH AMERICA CRISPR MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION) 

TABLE 13: NORTH AMERICA CRISPR MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)           

TABLE 14: NORTH AMERICA CRISPR MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)      

TABLE 15: EUROPE CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)      

TABLE 16: EUROPE CRISPR MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)      

TABLE 17: EUROPE CRISPR MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)           

TABLE 18: EUROPE CRISPR MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)           

TABLE 19: ASIA-PACIFIC CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)         

TABLE 20: ASIA-PACIFIC CRISPR MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)         

TABLE 21: ASIA-PACIFIC CRISPR MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)  

TABLE 22: ASIA-PACIFIC CRISPR MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)      

TABLE 23: LATIN AMERICA CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)    

TABLE 24: LATIN AMERICA CRISPR MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)    

TABLE 25: LATIN AMERICA CRISPR MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)           

TABLE 26: LATIN AMERICA CRISPR MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)      

TABLE 27: MIDDLE EAST AND AFRICA CRISPR MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)      

TABLE 28: MIDDLE EAST AND AFRICA CRISPR MARKET, BY PRODUCT, 2021-2028 (IN $ MILLION)      

TABLE 29: MIDDLE EAST AND AFRICA CRISPR MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)      

TABLE 30: MIDDLE EAST AND AFRICA CRISPR MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)           

List of Figures

FIGURE 1: MARKET ATTRACTIVENESS INDEX       

FIGURE 2: FUNDING SCENARIO SHARE, BY TYPE OF COMPANIES/ORGANIZATION         

FIGURE 3: KEY IMPACT ANALYSIS     

FIGURE 4: GLOBAL CRISPR MARKET, BY PRODUCT, 2020 & 2028 (IN %)       

FIGURE 5: GLOBAL CRISPR MARKET, BY PLASMIDS, 2021-2028 (IN $ MILLION)      

FIGURE 6: GLOBAL CRISPR MARKET, BY VECTORS, 2021-2028 (IN $ MILLION)       

FIGURE 7: GLOBAL CRISPR MARKET, BY PROTEINS, 2021-2028 (IN $ MILLION)      

FIGURE 8: GLOBAL CRISPR MARKET, BY DESIGNING TOOLS, 2021-2028 (IN $ MILLION) 

FIGURE 9: GLOBAL CRISPR MARKET, BY GRNA, 2021-2028 (IN $ MILLION)   

FIGURE 10: GLOBAL CRISPR MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)       

FIGURE 11: GLOBAL CRISPR MARKET, BY LIBRARY, 2021-2028 (IN $ MILLION)       

FIGURE 12: GLOBAL CRISPR MARKET, BY OTHER PRODUCTS, 2021-2028 (IN $ MILLION)           

FIGURE 13: GLOBAL CRISPR MARKET, BY APPLICATION, 2020 & 2028 (IN %)          

FIGURE 14: GLOBAL CRISPR MARKET, BY GENOME EDITING/GENETIC ENGINEERING, 2021-2028 (IN $ MILLION)

FIGURE 15: GLOBAL CRISPR MARKET, BY CRISPR PLASMID, 2021-2028 (IN $ MILLION)  

FIGURE 16: GLOBAL CRISPR MARKET, BY HUMAN STEM CELLS, 2021-2028 (IN $ MILLION)           

FIGURE 17: GLOBAL CRISPR MARKET, BY GRNA DATABASE/GENE LIBRARY, 2021-2028 (IN $ MILLION)   

FIGURE 18: GLOBAL CRISPR MARKET, BY CELL LINE ENGINEERING, 2021-2028 (IN $ MILLION)      

FIGURE 19: GLOBAL CRISPR MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)    

FIGURE 20: GLOBAL CRISPR MARKET, BY THERAPEUTICS AND DRUG DISCOVERY, 2021-2028 (IN $ MILLION)          

FIGURE 21: GLOBAL CRISPR MARKET, BY BIOLOGICAL RESEARCH, 2021-2028 (IN $ MILLION)      

FIGURE 22: GLOBAL CRISPR MARKET, BY AGRICULTURAL BIOTECH, 2021-2028 (IN $ MILLION)      

FIGURE 23: GLOBAL CRISPR MARKET, BY INDUSTRIAL BIOTECH, 2021-2028 (IN $ MILLION)           

FIGURE 24: GLOBAL CRISPR MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %) 

FIGURE 25: UNITED STATES CRISPR MARKET 2021-2028 (IN $ MILLION)      

FIGURE 26: CANADA CRISPR MARKET 2021-2028 (IN $ MILLION)         

FIGURE 27: UNITED KINGDOM CRISPR MARKET 2021-2028 (IN $ MILLION)   

FIGURE 28: GERMANY CRISPR MARKET 2021-2028 (IN $ MILLION)      

FIGURE 29: FRANCE CRISPR MARKET 2021-2028 (IN $ MILLION)          

FIGURE 30: SPAIN CRISPR MARKET 2021-2028 (IN $ MILLION)  

FIGURE 31: ITALY CRISPR MARKET 2021-2028 (IN $ MILLION)   

FIGURE 32: RUSSIA CRISPR MARKET 2021-2028 (IN $ MILLION)           

FIGURE 33: REST OF EUROPE CRISPR MARKET 2021-2028 (IN $ MILLION)   

FIGURE 34: CHINA CRISPR MARKET 2021-2028 (IN $ MILLION)  

FIGURE 35: JAPAN CRISPR MARKET 2021-2028 (IN $ MILLION) 

FIGURE 36: INDIA CRISPR MARKET 2021-2028 (IN $ MILLION)   

FIGURE 37: SOUTH KOREA CRISPR MARKET 2021-2028 (IN $ MILLION)         

FIGURE 38: ASEAN COUNTRIES CRISPR MARKET 2021-2028 (IN $ MILLION)

FIGURE 39: AUSTRALIA & NEW ZEALAND CRISPR MARKET 2021-2028 (IN $ MILLION)      

FIGURE 40: REST OF ASIA-PACIFIC CRISPR MARKET 2021-2028 (IN $ MILLION)     

FIGURE 41: BRAZIL CRISPR MARKET 2021-2028 (IN $ MILLION)

FIGURE 42: MEXICO CRISPR MARKET 2021-2028 (IN $ MILLION)          

FIGURE 43: REST OF LATIN AMERICA CRISPR MARKET 2021-2028 (IN $ MILLION) 

FIGURE 44: UNITED ARAB EMIRATES CRISPR MARKET 2021-2028 (IN $ MILLION)  

FIGURE 45: SAUDI ARABIA CRISPR MARKET 2021-2028 (IN $ MILLION)          

FIGURE 46: TURKEY CRISPR MARKET 2021-2028 (IN $ MILLION)          

FIGURE 47: SOUTH AFRICA CRISPR MARKET 2021-2028 (IN $ MILLION)        

FIGURE 48: REST OF MIDDLE EAST & AFRICA CRISPR MARKET 2021-2028 (IN $ MILLION)            

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;